Allurion Technologies Inc (OTCPK:ALUR)

Q1 2025 Allurion Technologies Inc Earnings Call Transcript

May 14, 2025 / 12:30 PM GMT

Release Date Price: $43.8 (+23.73%)

Transcript 10-Q8-K

Key Points

Positve

Allurion Technologies Inc (ALUR) achieved a first-quarter revenue of $5.6 million with a significant decrease in operating expenses by 45% compared to the previous year.
The company reported an expansion in gross margin to 75%, up from 73% in the prior year, indicating improved manufacturing efficiencies.
Allurion Technologies Inc (ALUR) is making progress towards FDA approval for its balloon product, with a PMA submission expected by the end of June.
The company is implementing a new B2B2C commercial model, which has shown over 40% growth in pilot clinics in Europe, suggesting potential for global expansion.
Allurion Technologies Inc (ALUR) has a strong cash position with $20 million in cash and equivalents, providing a runway for achieving key milestones such as FDA approval and profitability.

Negative

First-quarter revenue decreased from $9.4 million in the same period in 2024, primarily due to the temporary suspension of sales in France.
The company reported a net operating loss of $5.9 million, although this was an improvement from the previous year.
There is uncertainty around the timeline for the prospective trial of the combination therapy with GLP-1s, which could impact future revenue streams.
The restructuring initiatives, while improving efficiency, have led to reduced investments in sales and marketing, which may affect short-term growth.
The company faces challenges in achieving profitability for its ex-US business by the end of 2025, as outlined in their strategic plan.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

ALUR.N - Allurion Technologies Inc
Q1 2025 Allurion Technologies Inc Earnings Call
May 14, 2025 / 12:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Hello and welcome to the Euran first quarter earnings call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session, and if you would like to ask a question during this time, please press 1 on your telephone keypad.

I would now like to turn the conference over to Tara Brady. You may begin.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Good morning and thank you for joining us. Earlier today, Euron Technologies Inc. Issued a press release announcing financial results for the

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.